MiR-137-3p exacerbates the ischemia-reperfusion injured cardiomyocyte apoptosis by targeting KLF15

被引:0
|
作者
Tingting Zhao
Zhi Qiu
Yonghua Gao
机构
[1] Peace hospital attached to Changzhi,Department of Cardiology
[2] The Xiangya Hospital of central south university,Department of Cardiology
[3] Affiliated Hospital of Xuzhou Medical University,Department of Clinical Laboratory
关键词
Ischemia-reperfusion (I/R) injury; Hypoxia-reoxygenation (H/R) injury; miR-137-3p; I/R-induced apoptosis; KLF15;
D O I
暂无
中图分类号
学科分类号
摘要
Ischemia-reperfusion (I/R) injury is a kind of the tissue damage caused by an abrupt re-supplying tissue with blood after a period of ischemia or hypoxia. It contributes to a wide range of pathological processes including kidney injury, circulatory arrest, and especially cardiovascular disease. However, the underlying pathological mechanism is not fully elucidated. Previously, extensive studies demonstrated that miRNAs participate in the pathogenesis of I/R injury, such as I/R-induced cardiomyocyte apoptosis. Here, we found that miR-137-3p, a mature form of miR-137, was up-regulated in I/R-injured cardiomyocytes of myocardial infarction patients. Deficiency of miR-137-3p partly alleviated the cardiomyocyte apoptosis and oxidative stress induced by hypoxia-reoxygenation (H/R) treatment in H9c2 cells. Also, we provided evidences that miR-137-3p directly targeted the 3’ UTR of KLF15 mRNA to down-regulate its expression, and loss function of KLF15 significantly abolished the deleterious effects of ectopic miR-137-3p on cardiomyocytes both in vitro and in vivo. Collectively, these observations highlight a molecular perturbation in the pathogenesis of I/R injury in cardiomyocytes.
引用
收藏
页码:1013 / 1024
页数:11
相关论文
共 50 条
  • [1] MiR-137-3p exacerbates the ischemia-reperfusion injured cardiomyocyte apoptosis by targeting KLF15
    Zha, Tingting
    Qiu, Zhi
    Gao, Yonghua
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2020, 393 (06) : 1013 - 1024
  • [2] CTRP12 alleviates cardiomyocyte ischemia-reperfusion injury via regulation of KLF15
    Liao, Bo
    Tian, Xiaoyuan
    MOLECULAR MEDICINE REPORTS, 2022, 26 (01)
  • [3] Absence of miR-223-3p ameliorates hypoxia-induced injury through repressing cardiomyocyte apoptosis and oxidative stress by targeting KLF15
    Tang, Qing
    Li, Ming-Yue
    Su, Yu-Fei
    Fu, Jia
    Zou, Zong-Yi
    Wang, Yi
    Li, Shao-Ning
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2018, 841 : 67 - 74
  • [4] MiR-124 promotes ischemia-reperfusion induced cardiomyocyte apoptosis by targeting sphingosine kinase 1
    Liu, B-F
    Chen, Q.
    Zhang, M.
    Zhu, Y-K
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (16) : 7049 - 7058
  • [5] MiR-320 regulates cardiomyocyte apoptosis induced by ischemia-reperfusion injury by targeting AKIP1
    Tian, Zhi-Qiang
    Jiang, Hong
    Lu, Zhi-Bing
    CELLULAR & MOLECULAR BIOLOGY LETTERS, 2018, 23
  • [6] LncRNA GAS5 exacerbates myocardial ischemia-reperfusion injury through regulating serpina3 by targeting miR-137
    Liu, Zhengbing
    Hou, Lili
    Liu, Yu
    Gong, Jianbin
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2020, 306 : 9 - 9
  • [7] LncRNA UCA1 modulates cardiomyocyte apoptosis by targeting miR-143 in myocardial ischemia-reperfusion injury
    Yu, Si-yang
    Dong, Bo
    Zhou, Sheng-hua
    Tang, Liang
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 247 : 31 - 31
  • [8] MiR-137-3p rescue motoneuron death by targeting calpain-2
    Tang, Ying
    Fu, Rao
    Ling, Ze-Min
    Liu, Lin-lin
    Yu, Guang-yin
    Li, Wen
    Fang, Xin-yu
    Zhu, Zhe
    Wu, Wu-tian
    Zhou, Li-Hua
    NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2018, 74 : 74 - 85
  • [9] MicroRNA-93 inhibits ischemia-reperfusion induced cardiomyocyte apoptosis by targeting PTEN
    Ke, Zun-Ping
    Xu, Peng
    Shi, Yan
    Gao, Ai-Mei
    ONCOTARGET, 2016, 7 (20) : 28796 - 28805
  • [10] MiR-137-3p mechanisms of action and blood-brain barrier penetrating and neuron-targeting lipid nanoparticles deliver miR-137-3p for the treatment of Alzheimer's disease
    Zhou, Shiyue
    Huangfu, Shasha
    Yang, Hui
    Wang, Dewei
    Zheng, Xiaolei
    Bi, Jianzhong
    Xu, Shunliang
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2024, 100